IL-15 AGONISTS OVERCOME THE IMMUNOSUPPRESSIVE EFFECTS OF MEK INHIBITORS

Many signal transduction inhibitors being developed for cancer therapy target pathways that are also important for the proper function of anti-tumor lymphocytes, possibly weakening their therapeutic effects. Here we show that most inhibitors targeting multiple signaling pathways have especially stro...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Res
Asıl Yazarlar: Allegrezza, Michael J., Rutkowski, Melanie R., Stephen, Tom L., Svoronos, Nikolaos, Tesone, Amelia J., Perales-Puchalt, Alfredo, Nguyen, Jenny M., Sarmin, Fahmida, Sheen, Mee Rie, Jeng, Emily K., Tchou, Julia, Wong, Hing C., Fiering, Steven, Conejo-Garcia, Jose R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4873368/
https://ncbi.nlm.nih.gov/pubmed/26980764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-2808
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller